Gene Therapy Clinical Trial for Krabbe Disease is Recruiting Patients
7 lug 2021 ·
1 min. 45 sec.
![Gene Therapy Clinical Trial for Krabbe Disease is Recruiting Patients](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/d04f3f1086a4d6a97b3b5151ea6c7e25.jpg)
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
Tim Miller, PhD, CEO, President, and Co-Founder of Forge Biologics, discusses the phase 1/2 RESKUE study which will evaluate FBX-101 for the treatment of Krabbe disease. This clinical trial is...
mostra di più
Tim Miller, PhD, CEO, President, and Co-Founder of Forge Biologics, discusses the phase 1/2 RESKUE study which will evaluate FBX-101 for the treatment of Krabbe disease. This clinical trial is currently recruiting.
mostra meno
Informazioni
Autore | Peter Ciszewski, CheckRare |
Sito | - |
Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company